2015 Posters

(To view locked pages and locked PDFs you must have the password supplied to you by the ABSA office.)

Posters available for download as PDFs were indicated.

2015 International Poster Winner

INNOVATIVE APPLICATION OF LARGE SCALE GAS DECONTAMINATION METHODS AT LUGAR CENTER (TBILISI, GEORGIA) (PDF 414KB) (ID #2)
Tea Bakradze, Nikoloz Barbakadze, Ernie Pierce, Alexandre Kanyuk, Jason Mott, Richard G. Lugar Center for Public Health Research, Tbilisi, Georgia

2015 National Poster Winner

PERFORMANCE CHARACTERISTICS OF A PRIMARY CONTAINMENT SYSTEM FOR LARGE ANIMALS IN ABSL-4 (ID #3)
Vaughan P. Landon, Battelle National Biodefense Institute, Frederick, MD

DEVELOPMENT OF CULTIVO™ ULTRA PLUS TOTAL BIODECONTAMINATION PROCEDURE (PDF 658KB) (ID #4)
Kara Held, PhD., Aaron Johnson, Cheri Gaudet, The Baker Company, Sanford, ME

EVALUATION OF ETHIDIUM BROMIDE DESTROYER IN A RESEARCH LABORATORY (ID #5)
Ravinder Singh, Jay Krishnan, Catherine Robertson, Irene Martin, National Microbiology Laboratory, Winnnipeg, Manitoba, Canada

DEVELOPMENT OF A PROCESS CONTROL DEVICE (PCD) FOR USE IN MONITORING THE EFFECTIVENESS OF AN AUTOCLAVE PROCESSING INFECTIOUS/BIOHAZARDOUS WASTE) (PDF 667KB) (ID #6)
Edward Krisiunas, WNWN International, Inc, Burlington, CT
Charles Dippolito, Joseph Dippolito,Future Healthcare Systems, Mt. Vernon, NY

CHEMICAL AGENT COMPARISON DURING A MOCK DECONTAMINATION EVENT (ID #7)
Tom Boyle, Rowan University, Stratford, NJ

LINEARITY OF THE RELATIONSHIP BETWEEN CONCENTRATION AND CONTACT TIME FOR STERILIZATION WITH CHLORINE DIOXIDE GAS (PDF 1MB) (ID #8)
Kevin Lorcheim, Clordisys Solutions Inc, Lebanon, New Jersey, United States

CVRL BACKWESTON: A RE-ESTABLISHED LABORATORY ENVELOPE (ID #9)
Gordon J. Handziuk, Leslie Gartner, WSP|Parsons Brinckerhoff, Atlanta, GA
John Furlong, Office of Public Works, M&E Services, Trim, Co Meath, Ireland
John Moriarty, Central Veterinary Research Laboratory, Celbridge, Co Kildare, Ireland

POSSIBILITY OF PACKAGING TO PREVENT PATHOGEN SPLASH BY CAUSING OF MISS-PACKED WITH DRY ICE INTO THE INNER PACKING OF PATHOGEN TRANSPORT CONTAINERS (ID #10)
Shigeo Iki, Kiyoshi Tanabayashi, National Institute of Infectious Diseases, Tokyo, Japan

TRANSFERRING 100,000 SAMPLES OF RG 3 BIOLOGICAL AGENTS IN SINGAPORE – A LESSON LEARNED (PDF 936KB) (ID #11)
David Lam, Agnes Tan, Lynette Cheah, Jolly Su, Karen Lee, Singapore General Hospital, Singapore, Singapore

SHIPPING TRENDS OF ENTITIES THAT FREQUENTLY TRANSFER SELECT AGENTS AND TOXINS: 2003-2014 (ID #12)
Bryan Shelby, Vondguraus McClee, Denise Gangadharan, Robbin Weyant, Centers for Disease Control and Prevention, Atlanta, GA

PROFESSIONAL DEVELOPMENT OF BIORISK MANAGEMENT COORDINATORS FOR THE HEALTH SECTOR IN EGYPT (PDF 986KB) (ID #13)
Bassel Mamdouh, Central Health Laboratories, Cairo, Egypt
Geoffrey K. Phillips, USARMY MEDCOM USAMRMC, Ft Detrick, MD
Eric N. Cook, Sandia National Laboratories, Albuquerque, NM

RISING AWARENESS IN BIORISK MANAGEMENT IN GEORGIA (PDF 250KB) (ID #14)
Lela Bakanidze, Mariam Natsvlishvili, Georgian Biosafety Association, Tbilisi, Georgia
Neli Chakvetadze, National Center for Disease Control and Public Health, Tbilisi, Georgia

BRIDGING GAPS IN THE OVERSIGHT OF HUMAN PATHOGENS AND TOXINS AT AN INSTITUTIONAL LEVEL – A CANADIAN APPROACH (ID# 15)
John D. Campbell, Public Health Agency of Canada, Ottawa, Ontario, Canada
Ruthanne Huising, Desautels Faculty of Management, McGill University, Montreal, Quebec, Canada

IMPLEMENATION OF AN INTERNAL CERTIFICATION PROGRAM AT AN AUSTRALIAN UNIVERSITY (PDF 2MB) (ID #16)
Lisa M. van Duin, The University of Melbourne, Melbourne, Victoria, Australia

DHS REGULATORY COMPLIANCE PROGRAM – REVIEW PROCESSES AND COORDINATION EFFORTS (PDF 311KB) (ID #17)
Jason G. Ramage, Katherine Wirth, Dana Kiernan, Christopher O’Donnell, Tamika Knight, BAI/DHS S&T Compliance Assurance Program Office, Washington, DC
Cheryl Doerr, DHS S&T Compliance Assurance Program Office, Washington, DC

MEETING THE INTENT OF THE NATIONAL BIOSAFETY STEWARDSHIP INITIATIVE: USING A SUPPORTIVE AND SYSTEMATIC APPROACH (ID #18)
Robert Foreman, Northwestern University, Chicago, IL

IMPLEMENTATION OF A BIOSAFETY STEWARDSHIP INITIATIVE AT COLORADO STATE UNIVERSITY (#19)
Christine M. Johnson, Chaoping Chen, Robert P. Ellis, Kathryn M. Partin, Karen M. Dobos, Colorado State University, Fort Collins, CO

DEVELOPING AN ANIMAL BIOSAFETY LEVEL 2 AUDIT TO ASSIST STAFFS IN MEETING BIOSAFETY REQUIREMENTS IN UNIVERSITY OF ILLINOIS ANIMAL CARE FACILITIES (PDF 252KB) (ID #20)
Sara Myers, Linda Arseneau, University of Illinois at Urbana-Champaign, Urbana, IL

ASSESSMENT OF BIOSAFETY IMPLEMENTATION AND PERCEPTIONS BY LAB WORKERS IN A CENTRAL CLINICAL LAB OF A DEVELOPING COUNTRY: MOROCCO (ID #21)
Larbi Baassi, National Institute of Hygiene, Rabat, Morocco
Atef El Gendy, United States Naval Medical Research Unit No. 3, (NAMRU-3), Cairo, Egypt

MAXIMIZING THE VALUE OF AN INSTITUTION’S CONTAINMENT EQUIPMENT CERTIFICATION CONTRACT THROUGH INTERNAL SERVICE PROVIDOR COLLABORATION (ID #22)
Deborah Ferry, Frances L. Consiglio, Yale University, New Haven, CT

FUNERAL WORKERS’ PRACTICES IN KARACHI (ID #23)
Ambreen A. Alwani, Institute of Business Management, Karachi, Pakistan

CONSIDERATIONS FOR SELECTING THE CORRECT RESPIRATORY PROTECTIVE EQUIPMENT FOR WORK WITH PATHOGENIC MICRO-ORGANISMS (PDF 5MB) (ID #24)
Chuong Dai Do Thi, Katia Pauwels, Scientific Institute of Public health, Brussels, Belgium

DEVELOPMENT AND IMPLEMENTATION OF AN INCIDENCE RESPONSE PLAN FOR BIOPHARMA (RABAT MOROCCO) (PDF 972KB)(ID #25)
Said Mouhri, BIOPHARMA, Rabat, Morocco
Leo Njongmeta, University of Illinois—Chicago, Chicago, IL
Eric Cook, Sandia National Laboratories, Albuquerque, NM

MOBILIZATION FOR EBOLA VIRAL DISEASE OUTBREAK PREVENTION IN GEORGIA (PDF 2MB) (ID #26)
Shota Tsanava, Gela Mgeladze, Nino Modebadze, Natalia Abazashvili, Svetlana Chubinidze, M. Gafrindashvili, Ana Kasradze, National Center of Disease Control and Public Health, Tbilisi, Georgia

UNIQUE TREATMENT APPROACHES FOR THE TREATMENT OF A MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA INFECTION (PDF 579KB) (ID #28)
Kelly Harbourt, Notre Dame of Maryland University School of Pharmacy, Baltimore, MD
Manjari G. Joshi, University of Maryland School of Medicine, Baltimore, MD

EXCLUSION OF ATTENUATED SELECT AGENTS AND MODIFIED SELECT TOXINS (ID #29)
Jacinta Smith, Denise Gangadharan, Robbin Weyant, Centers for Disease Control and Prevention, Atlanta, GA

Biological Select Agents and Toxins (BSAT) Inventory Management Practices at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) (ID #30)
David J. Dohm, Ralph F. Tammariello Jr., Edward B. Selby, Teri L. Kissner, Uma Basavanna, Joyce E. Rochek, Md Mizanur Rahman, Virginia I. Roxas-Duncan, PhD, Samuel S. Edwin, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD

Institutional Review and Oversight of Dual Use Research of Concern (DURC) at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) (ID #31)
Teri L. Kissner, Uma Basavanna, Edward B. Selby, Ralph F. Tammariello Jr., David J. Dohm, Md Mizanur Rahman, Virginia I. Roxas-Duncan, PhD, Samuel S. Edwin, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD

Impact of Combined Regulatory Inspections on U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) (ID #32)
Md Mizanur Rahman, Virginia I. Roxas-Duncan, PhD, Samuel S. Edwin, Neal E. Woollen, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD